Large gap with delayed quotes
|
Last quote
10/24/2025
-
11:04:55
|
Bid
10/24/2025 -
11:11:13
|
Bid Volume |
Ask
10/24/2025 -
11:11:43
|
Ask Volume |
|---|---|---|---|---|
|
39.20
+0.95
(
+2.48% )
|
39.20
|
872 |
39.35
|
706 |
Analysis date: 21.10.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 03.10.2025.
Interest
Very strong
Very strong
Four stars since 12.09.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 12.09.2025 at a price of 35.25.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 03.06.2025.
4wk Rel Perf
3.82%
3.82%
The four-week dividend-adjusted overperformance versus STOXX600 is 3.82%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 14.10.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.15%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.40%.
Mkt Cap in $bn
2.69
2.69
With a market capitalization between $2 & $8bn, BB BIOTECH AG is considered a mid-cap stock.
G/PE Ratio
1.46
1.46
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
21.88
21.88
The estimated PE is for the year 2025.
LT Growth
25.40%
25.40%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
6.55%
6.55%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
91
91
For 1% of index variation, the stock varies on average by 0.91%.
Correlation
0.43
0.43
43.47% of stock movements are explained by index variations.
Value at Risk
4.69
4.69
The value at risk is estimated at CHF 4.69. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.07.2014
22.07.2014